Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic for HPV Reduction in Women
NCT05316064Phase 3Withdrawn
- Sponsor
- Universiti Sains Malaysia
- Start
- Dec 2021
- Primary completion
- Nov 2023
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Universiti Sains Malaysia. Primary endpoint: Changes in vaginal abundance of HPV at 12 weeks. Planned start Dec 2021; status: withdrawn.
Beyond the preview
Go deeper on NCT05316064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05316064.